I was thinking along the same lines last night. I never really had much expectations of the FSGS trial being a success and thought it would be an average, if not disappointing result. But that positive result gives me great confidence that the announcement on Monday will also be good news. Plus knowing what DXB has achieved over the past few years also helps aid my belief. Roll on Monday. Positive results will be a company maker, add in a pharmacy deal and the company will be cashed up to pursue FSGS, DMX 700, covid19 and any other new drugs in the pipeline.
DXB Price at posting:
74.0¢ Sentiment: Buy Disclosure: Held
(20min delay)